Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder.
Abstract
Studies investigating carbamazepine (CBZ) in the treatment of cocaine dependence have been inconsistent. In this study, cocaine-dependent individuals with (n = 57) and without (n = 82) affective disorder were compared in a 12-week, double-blind, placebo-controlled trial. Urine drug screens (UDS) and self-report of drug use were collected weekly. Affective symptoms were measured monthly. Subjects receiving CBZ attended more medication sessions (p = .03). The CBZ-treated affective group had a trend toward fewer cocaine-positive UDS (p = .08) and a significantly longer time to first cocaine use (p = .06). CBZ treatment did not have any impact on cocaine use in individuals without affective disorders.
Cites (5)
- A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I DepressionCalabrese, Joseph R., Bowden, Charles L., Sachs, Gary S., Ascher, John A., Monaghan, Eileen, Rudd, G. David, The Lamictal 602 Study Group · 1999 · The Journal of Clinical Psychiatry
- A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I DisorderBowden, Charles L. · 2000 · Archives of General Psychiatry
- Psychiatric Diagnoses of Treatment-Seeking Cocaine AbusersRounsaville, Bruce J. · 1991 · Archives of General Psychiatry
- Desipramine Facilitation of Initial Cocaine AbstinenceGawin, Frank H. · 1989 · Archives of General Psychiatry
- Desipramine Treatment of Cocaine Dependence in Methadone-Maintained PatientsArndt, Isabelle O. · 1992 · Archives of General Psychiatry
Cited by (11)
- Neurobiologic processes in drug reward and addictionAdinoff, Bryon · 2004 · Harvard Review of Psychiatry
- Predicting drug–disease associations through layer attention graph convolutional networkYu, Zhouxin, Huang, Feng, Zhao, Xiaohan, Xiao, Wenjie, Zhang, Wen · 2021 · Briefings in Bioinformatics
- Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances — Systematic review and meta-analysisHjorthøj, Carsten Rygaard, Hjorthøj, Anne Rygaard, Nordentoft, Merete · 2012 · Addictive Behaviors
- BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAPLingford-Hughes, AR, Welch, S, Peters, L, Nutt, DJ, With expert reviewers (in alphabetical order): Ball D, Buntwal N, Chick J, Crome I, Daly C, Dar K, Day E, Duka T, Finch E, Law F, Marshall EJ, Munafo M, Myles J, Porter S, Raistrick D, Reed LJ, Reid A, Sell L, Sinclair J, Tyrer P, West R, Williams T, Winstock A · 2012 · Journal of Psychopharmacology
- Mood Disorders and Substance Use Disorder: A Complex ComorbidityQuello, Susan, Brady, Kathleen, Sonne, Susan · 2005 · Science & Practice Perspectives
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder. https://app.cochat.ai/papers/10.1037//1064-1297.10.3.276
- The paper
- Brady, K. T., Sonne, S. C., Malcolm, R. J., Randall, C. L., Simpson, K., Dansky, B. S., Roberts, J. S., & Brondino, M. (2002). Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037//1064-1297.10.3.276
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.